Literature DB >> 9785332

Anemia and quality of life in cancer patients: impact of transfusion and erythropoietin.

M L Thomas1.   

Abstract

Anemia is a frequent complication of cancer and its treatment and can have a significant impact on one's quality of life. The utility of mechanisms currently used to ameliorate the anemia (i.e. transfusion and erythropoietin) is reviewed vis-à-vis improving quality of life.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9785332

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


  4 in total

1.  Resource utilisation and time commitment associated with correction of anaemia in cancer patients using epoetin alfa.

Authors:  Kenneth R Meehan; N Simon Tchekmedyian; Robert E Smith; Joel Kallich
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

2.  Serum erythropoietin level in anemic cancer patients.

Authors:  M Ozguroglu; B Arun; G Demir; F Demirelli; N M Mandel; E Buyukunal; S Serdengecti; B Berkarda
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.064

Review 3.  Epoetin Beta: a review of its clinical use in the treatment of anaemia in patients with cancer.

Authors:  Susan M Cheer; Antona J Wagstaff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Antianemic Treatment of Cancer Patients in German Routine Practice: Data from a Prospective Cohort Study-The Tumor Anemia Registry.

Authors:  Tilman Steinmetz; Jan Schröder; Margarete Plath; Hartmut Link; Michèle Vogt; Melanie Frank; Norbert Marschner
Journal:  Anemia       Date:  2016-02-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.